Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.410 Biomarker group HPO
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.410 CausalMutation group CGI
Entrez Id: 4486
Gene Symbol: MST1R
MST1R 		0.100 Biomarker group HPO
Entrez Id: 79728
Gene Symbol: PALB2
PALB2 		0.100 CausalMutation group CLINVAR
Entrez Id: 7424
Gene Symbol: VEGFC
VEGFC 		0.010 Biomarker group BEFREE These results suggest that VEGF-C and VEGFR-3 have a role in the development of the nasal submucosal vascular plexus and in its normal function and that they are associated with angiogenesis in nasal and nasopharyngeal tumors. 10880369 2000
Entrez Id: 2324
Gene Symbol: FLT4
FLT4 		0.010 Biomarker group BEFREE These results suggest that VEGF-C and VEGFR-3 have a role in the development of the nasal submucosal vascular plexus and in its normal function and that they are associated with angiogenesis in nasal and nasopharyngeal tumors. 10880369 2000
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1 		0.010 AlteredExpression group LHGDN [Expression of human cytochrome P450 2E1 gene in embryonic nasopharynx, nasopharyngeal cancer cell lines and tissue]. 12452057 2002
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.410 Biomarker group BEFREE In this study, p53 protein immunoreactivity was investigated in paraffin sections of primary nasopharyngeal tumors and metastatic cervical lymph nodes and association with clinical and histopathological characteristics was evaluated. 15523893 2005
Entrez Id: 1909
Gene Symbol: EDNRA
EDNRA 		0.300 Biomarker group CTD_human Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma. 17032313 2006
Entrez Id: 1548
Gene Symbol: CYP2A6
CYP2A6 		0.300 Biomarker group CTD_human Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma. 16377082 2006
Entrez Id: 4313
Gene Symbol: MMP2
MMP2 		0.300 Biomarker group CTD_human Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma. 17607721 2007
Entrez Id: 11197
Gene Symbol: WIF1
WIF1 		0.300 Biomarker group CTD_human The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. 17384664 2007
Entrez Id: 9770
Gene Symbol: RASSF2
RASSF2 		0.300 Biomarker group CTD_human Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. 17013896 2007
Entrez Id: 2697
Gene Symbol: GJA1
GJA1 		0.010 AlteredExpression group BEFREE Thus, the amplified Cx43 expression by an antitumor agent, an HDAC inhibitor, may have great potential as a growth inhibitor for nasopharyngeal tumors. 17487363 2007
Entrez Id: 3082
Gene Symbol: HGF
HGF 		0.010 Biomarker group LHGDN Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK. 18789327 2008
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5 		0.010 AlteredExpression group LHGDN Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. 18384219 2008
Entrez Id: 5216
Gene Symbol: PFN1
PFN1 		0.010 AlteredExpression group LHGDN Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. 18384219 2008
Entrez Id: 3680
Gene Symbol: ITGA9
ITGA9 		0.100 GeneticVariation group GWASCAT A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. 19478819 2009
Entrez Id: 3105
Gene Symbol: HLA-A
HLA-A 		0.100 GeneticVariation group GWASCAT Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. 19664746 2009
Entrez Id: 55504
Gene Symbol: TNFRSF19
TNFRSF19 		0.400 GeneticVariation group GWASCAT A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010
Entrez Id: 2122
Gene Symbol: MECOM
MECOM 		0.400 Biomarker group CTD_human A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010
Entrez Id: 55504
Gene Symbol: TNFRSF19
TNFRSF19 		0.400 Biomarker group CTD_human A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010
Entrez Id: 2122
Gene Symbol: MECOM
MECOM 		0.400 GeneticVariation group GWASCAT A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010
Entrez Id: 100048912
Gene Symbol: CDKN2B-AS1
CDKN2B-AS1 		0.100 GeneticVariation group GWASCAT A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010
Entrez Id: 3106
Gene Symbol: HLA-B
HLA-B 		0.100 GeneticVariation group GWASCAT A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. 20512145 2010